Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|March 26, 2016
Assessing the therapeutic potential of lab-made hepatocytesMilad Rezvani, Andrew A Grimm, Holger WillenbringThe Journal of Biological Chemistry|September 24, 2004
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cellsJavier R Revollo, Andrew A Grimm, Shin-ichiro ImaiCurrent Opinion in Gastroenterology|February 3, 2007
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammalsJavier R Revollo, Andrew A Grimm, Shin-ichiro ImaiJournal of Health Economics and Outcomes Research|January 10, 2025
Glycogen Storage Disease Type Ia: A Retrospective Claims Analysis of Complications, Resource Utilization, and Cost of CareEliza Kruger, Justin Nedzesky, Nina Thomas, et al.Aging Cell|December 24, 2010
A nutrient-sensitive interaction between Sirt1 and HNF-1α regulates Crp expressionAndrew A Grimm, Cynthia S Brace, Ting Wang, et al.Cell Metabolism|August 16, 2005
Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in miceKathryn A Moynihan, Andrew A Grimm, Marie M Plueger, et al.Cell Stem Cell|June 4, 2016
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver FibrosisMilad Rezvani, Regina Español-Suñer, Yann Malato, et al.JPEN. Journal of Parenteral and Enteral Nutrition|September 10, 2019
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III StudySamuel A Kocoshis, Russell J Merritt, Susan Hill, et al.JPEN. Journal of Parenteral and Enteral Nutrition|December 11, 2020
Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical StudiesSusan Hill, Beth A Carter, Valeria Cohran, et al.Pageof 1